India’s TB Fight Gains Momentum with Sharp Decline and Ongoing Challenges

Overview: According to the WHO Global TB Report 2025, India has achieved a 21% reduction in tuberculosis cases from 2015 to 2024 — nearly double the global decline of 12%. This success highlights India’s strong commitment under the National TB Elimination Programme (NTEP) to make the country TB-free by 2025.

Riyaz

Nov-13-2025

India’s TB Fight Gains Momentum with Sharp Decline and Ongoing Challenges

WHO Global TB Report 2025, from 2015 to 2024, the incidence of tuberculosis in India has decreased by an impressive 21 per cent, which is almost twice the rate of decrease in the world, at 12 per cent. This is a tremendous development that gives evidence to the fact that India tries its best within the framework of the National TB Elimination Programme (NTEP,) and it strives to eradicate TB by 2025. The nation has increased the availability of free diagnostics, treatment and online surveillance systems, which results in the early detection and enhanced recovery. The number of TB deaths has also decreased considerably, which testifies to India being serious about enhancing the healthcare systems and providing a model of disease containment and increase of population health worldwide.

India Strengthens Fight Against TB Through NTEP Initiative

The National TB Elimination Programme (NTEP) is the major initiative of India to eradicate tuberculosis by the year 2025, before the global deadline of 2030.
It offers free treatment and diagnosis via the government health facilities in the country.
The programme has incorporated the advanced molecular tests, such as CBNAAT and TrueNat to detect TB quickly and correctly.
An online platform (Nikshay) monitors TB patients to guarantee real-time monitoring and adherence to treatment.
Nikshay Poshan Yojana will entitle TB patients to 1000 monthly nutritional support.
The incidence of TB in India has reduced by 21, and this shows how the programme has been successful in raising awareness, diagnosing and providing care.

Conclusion

The battle against tuberculosis in India has a good momentum and the number of cases is reducing drastically, attesting to the success of national healthcare programs. Nevertheless, such obstacles as gaps in the early detection, stigma, and adherence to treatment still exist. India needs to continue investing, creating awareness and innovation in order to realize its TB-free nation by 2025 and maintain the long-term development.